- Home
- ATLO vs TLSI Comparison
ATLO vs TLSI Comparison
Compare ATLO & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- TLSI
- Stock Information
- Founded
- ATLO 1903
- TLSI 2010
- Country
- ATLO United States
- TLSI United States
- Employees
- ATLO N/A
- TLSI N/A
- Industry
- ATLO Major Banks
- TLSI Medical Specialities
- Sector
- ATLO Finance
- TLSI Health Care
- Exchange
- ATLO Nasdaq
- TLSI Nasdaq
- Market Cap
- ATLO 177.0M
- TLSI 150.0M
- IPO Year
- ATLO N/A
- TLSI N/A
- Fundamental
- Price
- ATLO $20.52
- TLSI $4.58
- Analyst Decision
- ATLO
- TLSI Strong Buy
- Analyst Count
- ATLO 0
- TLSI 5
- Target Price
- ATLO N/A
- TLSI $10.90
- AVG Volume (30 Days)
- ATLO 10.1K
- TLSI 102.3K
- Earning Date
- ATLO 11-07-2025
- TLSI 11-13-2025
- Dividend Yield
- ATLO 3.89%
- TLSI N/A
- EPS Growth
- ATLO 43.95
- TLSI N/A
- EPS
- ATLO 1.53
- TLSI N/A
- Revenue
- ATLO $57,731,000.00
- TLSI $35,990,000.00
- Revenue This Year
- ATLO N/A
- TLSI $56.79
- Revenue Next Year
- ATLO N/A
- TLSI $54.15
- P/E Ratio
- ATLO $13.41
- TLSI N/A
- Revenue Growth
- ATLO 12.59
- TLSI 45.50
- 52 Week Low
- ATLO $15.69
- TLSI $3.42
- 52 Week High
- ATLO $20.75
- TLSI $5.88
- Technical
- Relative Strength Index (RSI)
- ATLO 68.10
- TLSI 50.66
- Support Level
- ATLO $20.00
- TLSI N/A
- Resistance Level
- ATLO $20.72
- TLSI $5.10
- Average True Range (ATR)
- ATLO 0.33
- TLSI 0.25
- MACD
- ATLO 0.02
- TLSI -0.24
- Stochastic Oscillator
- ATLO 87.83
- TLSI 85.69
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.